Pharmaceutical Product Supply – Fluticasone Propionate Nasal Spray

The contract involves the manufacture or supply of 10 units of Fluticasone Propionate Nasal Spray, identified by NSN 6505014107226, a commercial prescription nasal corticosteroid used for treating allergic rhinitis and other nasal conditions. The product must fully comply with both Defense Logistics Agency and Food and Drug Administration standards, ensuring it meets rigorous quality, safety, and efficacy requirements for government use. The supply is being procured under a subcontract tied to the Department of Defense, with the Defense Logistics Agency listed as the overseeing agency and the NAICS code 325412 confirming the manufacturing classification for pharmaceutical preparations. The contract was posted on July 18, 2026, and is linked to a specific award and delivery reference through the DIBBS system, indicating it is part of a larger procurement effort managed by the federal supply chain. While no specific place of performance or point of contact is provided, the commercial nature of the product and the regulatory compliance mandates imply that the supplier must be an established pharmaceutical manufacturer with validated production processes and documentation capable of supporting federal procurement audits. The contract does not specify any set-aside status, meaning it is open to all qualified vendors regardless of business size or ownership classification.